Levetiracetam Thame

Levetiracetam, the active ingredient in Levetiracetam Thame, is an antiepileptic presented as an oral formulation for oral use. It is used to treat various seizure types in patients with epilepsy.

GNH USA supplies Levetiracetam Thame as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic drug that modulates neuronal excitability to control seizure activity.

Partial seizures: reduces the frequency and severity of focal onset seizures. Generalized tonic‑clonic seizures: helps prevent convulsive episodes. Myoclonic seizures: diminishes rapid, involuntary muscle jerks associated with this seizure type.

Levetiracetam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness - Fatigue - Somnolence - Irritability

Serious or Rare Side Effects: - Severe allergic reactions (e.g., anaphylaxis) - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Suicidal thoughts or behavior - Significant skin rash with systemic involvement - Blood dyscrasias such as agranulocytosis

When prescribing levetiracetam, clinicians should consider several safety aspects.

Renal impairment: adjust dose based on renal function. Hepatic dysfunction: monitor liver enzymes periodically. Psychiatric symptoms: observe for mood changes or depression. Pregnancy: risk category unknown; discuss potential benefits and risks with the patient. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Levetiracetam can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may lower levetiracetam plasma concentrations. - Enzyme‑inducing antiepileptics (phenytoin, phenobarbital): can reduce therapeutic effect.

Moderate Interactions (Monitor Closely): - CNS depressants (benzodiazepines, alcohol): may increase sedation. - Other antiepileptics (valproate, lamotrigine): monitor for additive side effects. - Oral contraceptives: levetiracetam may reduce contraceptive effectiveness.